🔗 Share this article

An underground market for unlicensed slimming medications is being driven by social media fitness personalities and vendors on communication apps, based on new investigations.

Investigational Drug Gaining Popularity Online

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning properties. Followers are encouraged to message these profiles directly for source information, while also obtaining discount codes.

Active Commerce on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where communities with numerous of participants share “before and after” photos, injection guides and claims of next-day British shipping. Vendors market the drug there before directing buyers to other platforms for purchases.

Understanding Retatrutide

This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could assist individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Medical Experts Express Worries

Nevertheless, doctors and pharmacists have warned that the sale of what remains an unlicensed drug in the United Kingdom is worrisome and could lead to individuals administering substances of uncertain source.

Some professionals said the demand for the experimental drug could be linked to the rising cost of approved slimming treatments such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that must not be marketed or distributed for human use under the British medical regulations.

Several content creators attempt to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still violate medicines, marketing, and consumer laws, risking fines, prosecution or prison.

Platform Reaction and Content Removal

Based on TikTok, the platform has removed violative material and banned related hashtags and search suggestions. The company said it was committed to keeping the platform secure and allocating resources in enhancing enforcement strategies.

Digital Marketplace Operations

Research also found groups with up to nine thousand participants selling the experimental drug using Telegram's integrated discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays channels with numerous of members, filled with images of weight loss, positive testimonials and detailed guides for mixing or administering at residence.

After minutes of entering one community, a vendor posted WhatsApp details, where most transactions occur. The seller provided an instruction manual and promised delivery within 48 hours. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a image of a supposed testing documentation. None asked about weight, medical conditions or previous experience.

Item Information and Costs

Inside these communities, posts show black plastic packages with Royal Mail labels, stating to include new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at residence with purified liquid, or ready-to-use injectors usually priced at 160 pounds for 20 milligrams. When asked how much time a injector should be used, vendors give contradictory answers varying between a several days to “depends on your body”.

Platform Oversight and Security Actions

A representative for the messaging service said it actively moderated harmful material on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are injecting substances they can’t verify. Even if the research behind retatrutide is sound, these digital products may not include what they advertise,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the surge in interest to current price rises for authorized weight-loss medications such as Mounjaro. “With costs increasing, individuals are using online platforms. But fake treatments are extremely risky. You cannot know what’s inside or whether the environment they were produced in was sterile,” she said.

Her staff has previously seen patients injured by self-injection from unverified suppliers. “We recognize the disappointment, but buying from messaging apps or communication platforms is taking chances with your well-being,” said Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said the substance was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they said, noting that any product “misleadingly claiming itself as a company experimental substance not yet approved … may expose users to possibly serious health risks”.